The NanoHybrid is a unique DNA/PNA (Peptide Nucleic Acid) based multi-modal biomolecule amplifying platform that can detect specific antibodies and protein analytes, rapidly and quantitatively, directly from serum or whole blood. These nano-explorers allow POC medical devices and self-testing tools to detect viruses and tumors with reduced time, reduced cost and with unparalleled accuracy.
The NanoHybrid platform was also developed for the application
of personalized medicine. This platform has recently demonstrated clinically relevant therapeutic drug monitoring (TDM) capabilities for a major oncology therapy, with a long list of other product prototypes in development. The NanoHybrid platform is also compatible with high- throughput automation applications, for the simultaneous analysis of hundreds of samples.